AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.55pm 30/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 68.0¢ | Day High | 68.5¢ | Day Low | 68.0¢ | |||
| Daily Volume | 33635 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 67.5¢ | 145000 | 0 | 68.5¢ | 124100 | |
Directors & Senior Management
| Mr. Andrew Metcalfe | Joint Company Secretary |
| Mr. Darren Katz | Portfolio Manager |
| Ms. Diana D'Ambra | Independent Non-Executive Director |
| Mr. John Bruce Abernethy | Director |
| Mr. Julian John Gosse | Non Executive Director |
| Mr. Marc Ariel Schwartz | Non-Executive Director |
| Mr. Michael Kloeckner | Portfolio Manager |
| Mitchell Sneddon | Portfolio Manager |
| Philip J. Lord | Portfolio Manager |
| Mr. Richard J. A. Proctor | Company Secretary |
| Mr. Ronni David Chalmers | Director |
Data source: ADVFN
